Runto Co., Ltd: Obtained the registration certificate for methylergometrine maleate injection.

On April 3rd, Runto Corporation announced that the company has received the "Drug Registration Certificate" for the injection of Metoprolol Hydrochloride, a drug used for cardiac stress testing. This product is used for myocardial perfusion imaging with isotopes to evaluate myocardial ischemia. The drug, developed by the company, is the first globally innovative drug of its kind and the only beta-receptor agonist class isotope myocardial perfusion imaging cardiac stress testing drug approved in China. Its safety and efficacy have been verified through multiple clinical trials, providing a new option for diagnosing myocardial ischemia.